Cargando…
A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression
To determine if a multi-analyte cerebrospinal fluid (CSF) peptide signature can be used to differentiate Alzheimer’s Disease (AD) and normal aged controls (NL), and to determine if this signature can also predict progression from mild cognitive impairment (MCI) to AD, analysis of CSF samples was don...
Autores principales: | Llano, Daniel A., Bundela, Saurabh, Mudar, Raksha A., Devanarayan, Viswanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542644/ https://www.ncbi.nlm.nih.gov/pubmed/28771542 http://dx.doi.org/10.1371/journal.pone.0182098 |
Ejemplares similares
-
Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
por: Llano, Daniel A., et al.
Publicado: (2020) -
Reported Hearing Loss in Alzheimer’s Disease Is Associated With Loss of Brainstem and Cerebellar Volume
por: Llano, Daniel A., et al.
Publicado: (2021) -
A PRIM approach to predictive-signature development for patient stratification
por: Chen, Gong, et al.
Publicado: (2015) -
CSF proteomic signature predicts progression to Alzheimer's disease dementia
por: Vromen, Eleonora M., et al.
Publicado: (2022) -
Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis
por: Kwok, Susanna S., et al.
Publicado: (2022)